Cite
HARVARD Citation
Kumar, S. et al. (2017). Efficacy and safety of once‐daily insulin degludec/insulin aspart compared with once‐daily insulin glargine in participants with Type 2 diabetes: a randomized, treat‐to‐target study. Diabetic medicine. 34 (2), pp. 180-188. [Online].